Core Education

Our Core Education articles help you understand your cancer so you are equipped to find a good care team, ask appropriate questions, and become your own best advocate.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

What is Pancytopenia? Symptoms, Causes, & Treatments

October 11, 2024

Are your blood counts low? It may be pancytopenia. Learn about its causes and treatments.

Beyond Symptom Management: Modifying the Disease Course in Myelofibrosis

September 12, 2024

Learn about JAK inhibitors and new disease-modifying therapies for myelofibrosis to go beyond symptom management and potentially improve survival rates.

The Bodily Mechanisms That Can Lead to Myelofibrosis

August 29, 2024

Ever wondered how a simple genetic change can lead to a complex disease like myelofibrosis? Learn about JAK2 and JAK2 mutations.

What Is The Prognosis Of A Myelofibrosis Patient?

July 22, 2024

Receiving a diagnosis like myelofibrosis can often bring forward the questions "How long will I live with this disease?"

What Does Erythrocytosis Mean?

July 03, 2024

Erythrocytosis: Elevated red blood cells harm circulation and function. Causes include low oxygen, smoking, etc. Diagnosis via CBC; treat the underlying cause.

Extramedullary Hematopoiesis in People with Myelofibrosis

July 02, 2024

People with myelofibrosis often experience enlarged organs such as the liver and spleen. Learn why and what treatments might help.

Why Do I Have Myelofibrosis?

June 25, 2024

This article reviews the causes of myelofibrosis and its symptoms, risk factors, and potential progression to leukemia. Learn more about its prognosis here..

What Is The Difference Between Chronic And Acute Leukemia?

June 21, 2024

Discovering Leukemia Types: Acute vs. Chronic - Unveiling Cell Differences, Genetic Triggers, and Treatment Approaches.

Can Myelofibrosis Progress to Leukemia?

June 07, 2024

Learn about secondary acute leukemia from myeloproliferative neoplasms (MPNs), its unique characteristics, and the need for advanced treatment options.